Skip to main content
Workforce and Demographics · LFP-06.02

The 55-to-64 Cohort: Senior Entrepreneurs in the Pre-Medicare Coverage Desert

By Syam Adusumilli · 8 min read
In a Hurry? Read the executive summary.

LFP-06.02 | Sharp Analysis | Series 06: The Populations

The decade between age 55 and Medicare eligibility at 65 is the most expensive coverage period in the working years and the least adequately served by existing product categories. The 55-to-64 cohort has spending rates nearly double those of workers in their late thirties, chronic condition prevalence that approaches 70%, and a trajectory toward increasingly expensive pharmaceutical therapies for the conditions they are acquiring at the highest rates. They also have something most high-cost coverage populations do not: purchasing power. The coverage gap this cohort faces is not a market access failure. It is a product design failure, and the distinction matters because a different conclusion flows from each diagnosis.

The Demographic Picture
#

Business formation among Americans aged 55 to 64 has been trending older for three decades, and the trajectory accelerated after 2020. The Kauffman Foundation’s longitudinal analysis of the Current Population Survey found that those aged 55 to 64 represented 14.8% of new entrepreneurs in 1996. By 2019, that share had risen to approximately 25.1%. Among all age groups, the 55-to-64 cohort also shows the highest share of opportunity entrepreneurs: those who started a business by choice rather than necessity, at just over 88%. The motivation matters for insurance purchasing, because opportunity entrepreneurs bring stable financial resources and willingness to pay for quality coverage that necessity entrepreneurs often do not.

The drivers of senior entrepreneurship are structural and reinforcing. Accumulated savings and home equity provide startup capital. Professional networks built over careers produce client relationships without advertising spend. Reduced family obligations as children become adults create schedule flexibility. The Federal Reserve’s Survey of Consumer Finances places median net worth for households headed by someone aged 55 to 64 at $364,500, compared to $140,800 for households headed by someone aged 35 to 44. The income and asset profile of this cohort is not the barrier to coverage.

There is also an involuntary pathway that produces the same coverage problem from a different starting point. AARP research shows that 78% of older workers have seen or experienced age discrimination in the workplace. Corporate restructuring disproportionately affects workers over 50. When displacement occurs in this age range, whether voluntary or not, the resulting business or consulting practice carries the same coverage need as a deliberately planned venture. The consulting practice of a displaced 57-year-old Chief Marketing Officer and the business launched by a 61-year-old who left deliberately to pursue an opportunity are actuarially identical. Both are small groups with high-cost, complex health profiles and no adequate product designed for them.

The Health Complexity and Cost Profile
#

Healthcare spending rises with age throughout adulthood and accelerates in the decade before Medicare eligibility. Peterson-KFF Health System Tracker analysis of 2023 MEPS data found that people aged 55 and over accounted for 57% of total health spending despite representing only 30% of the population. The concentration of spending in the pre-Medicare working years is not an artifact of Medicare enrollment pulling high-need individuals to federal coverage; this spending occurs before Medicare eligibility begins.

Chronic condition prevalence drives the spending differential. The Centers for Disease Control and Prevention’s National Health Interview Survey shows that 72% of adults aged 55 to 64 have at least one chronic condition, compared to 44% of adults aged 35 to 44. The conditions are not merely present. They are the conditions that generate ongoing pharmaceutical costs, specialist visits, monitoring, and periodic hospitalization: hypertension, hyperlipidemia, type 2 diabetes, osteoarthritis, and depression at rates two to three times those of the 35-to-44 cohort.

The pharmaceutical pipeline is adding therapies that will increase spending for this age cohort faster than for younger populations. PCSK9 inhibitors for cardiovascular disease prevention, approved by the FDA for high-risk patients, carry annual costs of approximately $5,000 to $6,000 after manufacturer discounts. The Alzheimer’s therapies lecanemab (approved 2023, marketed as Leqembi) and donanemab (approved 2024, marketed as Kisunla) target patients with early-stage cognitive decline, a condition that presents primarily in adults over 55, and carry annual drug costs exceeding $26,000 per patient before infusion and monitoring costs. Milliman’s health cost guidelines for commercial insurance show the 55-to-64 cohort at 1.8 to 2.2 times the cost of the 25-to-34 baseline, depending on plan design and geography. That multiplier is embedded in stop loss underwriting, marketplace age rating, and COBRA premium calculations.

Stop loss carriers price for this reality. A group composed primarily of workers aged 55 to 64 faces specific attachment points materially higher than a demographically mixed group of the same size. The underwriting economics of a 5-person group where the average age is 59 look fundamentally different from a 5-person group averaging 34. Both have 5 members. Only one is an attractive risk at standard small group attachment points.

The Coverage Options and Their Failures
#

The 55-to-64 entrepreneur leaving corporate employment encounters four coverage options. Each fails this population in a specific, identifiable way, and the specific failure mode is worth describing because each forecloses a different solution.

The ACA marketplace provides coverage regardless of health status. Age rating is permitted up to a 3-to-1 ratio of older to younger premiums, which means a 60-year-old pays up to three times the premium of a 21-year-old for the same plan. Premium subsidies apply for households between 100% and 400% of the federal poverty level, and the enhanced subsidies created by the American Rescue Plan Act and extended through the Inflation Reduction Act have softened the burden for moderate-income enrollees. For the 55-to-64 entrepreneur earning $120,000 to $200,000 annually, however, enhanced subsidies phase out before their income, and benchmark Silver premiums for a 60-year-old in a metropolitan area routinely range from $1,100 to $1,500 per month. Over the seven to ten years between departure from employer coverage and Medicare eligibility, unsubsidized marketplace costs accumulate to six figures in premiums alone, before deductibles and coinsurance.

COBRA provides continuity but not a durable solution. The departing employee pays the full group premium, both employer and employee share, plus a 2% administrative fee. For someone leaving a large-employer plan, COBRA premiums of $700 to $1,500 monthly are common for individual coverage. COBRA expires at 18 months. It does not address the coverage need for the new business the entrepreneur is forming, and it does not provide coverage for the business’s employees.

Level funded requires adequate group size. Conventional stop loss underwriting from carriers such as Sun Life, HM Insurance Group, Tokio Marine HCC, and Voya requires 10 or more enrolled lives before quoting at standard small group terms. Many businesses formed by 55-to-64 entrepreneurs begin with 1 to 5 employees: the founder, a spouse or partner, and an initial small team. Below 10 lives, stop loss carriers typically either decline to quote or price attachment points high enough that the stop loss protection is nominal. The level funded product exists as a category. It does not exist as a practical option for the group sizes this cohort typically forms in the first three to five years of the business.

ICHRA, the Individual Coverage Health Reimbursement Arrangement established in 2019, allows employers to reimburse employees tax-free for individual market coverage. The mechanism is sound. The limitation is that ICHRA’s value depends entirely on the quality and affordability of the individual market where the employee lives. In states with competitive, well-populated ACA marketplaces and multiple carrier options, ICHRA can bridge the gap for employees who do not face the full age-rating penalty. For the 55-to-64 entrepreneur themselves, ICHRA does not solve the individual market premium problem. The owner receiving ICHRA reimbursement is still purchasing individual coverage at age-rated premiums the reimbursement may only partially offset. The HRA Council’s 2024 ICHRA market report shows adoption growing substantially in larger firms, but penetration among small employers where the owner is also the highest-cost potential enrollee remains limited.

The Market Opportunity and the Design Gap
#

The underserved population is substantial enough to be worth quantifying precisely. The Bureau of Labor Statistics Current Population Survey shows approximately 4.3 million self-employed workers aged 55 to 64 in 2023. Adding employees of small businesses owned by this cohort extends the population further. Not all of these individuals have inadequate coverage. Some are enrolled in a spouse’s employer plan. Some have high enough income to absorb marketplace premiums without financial strain. But among those without access to a spouse’s employer group coverage and earning too much for meaningful subsidy support, the coverage problem is structural.

What this population needs is specific and currently unavailable as a coherent product: group-quality coverage with the network access and benefit design of employer-sponsored insurance, priced to reflect risk-sharing across a small pool of members rather than individual market rates, available for groups of 2 to 10 lives at stop loss terms that do not require the underwriting volume that makes the product viable only above 10 enrolled members. The ACA marketplace provides individual-market coverage at individual-market rates. ICHRA passes the individual-market problem to the employee. Level funded requires more lives than this cohort’s businesses typically have. COBRA expires.

The gap exists not because the market has failed to see the population, but because the regulatory and product architecture of employer-sponsored insurance is optimized for a different population: larger groups with younger, healthier workforces, where the employer’s contribution meaningfully reduces premium cost per worker and stop loss underwriting works at standard terms. The 55-to-64 entrepreneur with 4 employees does not fit this architecture, and no modification of existing products within current regulatory parameters closes the gap.

This population feeds directly into Series 15 and Series 16. The product architecture for a TPA serving the 1-to-50 market must either address the below-10-lives problem for high-age, high-cost groups or explicitly acknowledge that this cohort remains outside the viable market. Leaving the analysis implicit is a design choice with consequences. Series 16 examines the specific product logic that might serve the post-Medicare-eligible continuation of these businesses and their owners. The 55-to-64 coverage gap is the entry point for that analysis.

How this article connects to others in Blue Gray Matters.

The 55-to-64 cohort's health profile, with 70 percent chronic condition prevalence and spending that accounts for 57 percent of total health expenditures despite representing 30 percent of the population, presents the most adverse small group underwriting scenario; LFP-02.03 documents how carriers weight age, prescription drug history, and chronic condition indicators, and this cohort sits at the unfavorable end of every factor, which explains why level funded economics are challenging for groups concentrated in this age range.
GLP-1 adoption rates are highest among the 55-to-64 cohort, where metabolic disease prevalence and physician prescribing patterns converge; the cost trajectory LFP-09.03 documents for GLP-1 medications applies most directly to the entrepreneurial older worker this article examines, making pharmacy benefit design decisions particularly consequential for level funded plans serving groups with substantial 55-to-64 enrollment.
The chronic condition complexity of this cohort requires benefit design that supports ongoing condition management, specialist access, and pharmaceutical coverage at levels beyond standard small employer plan design; LFP-11.09 examines whole-person benefits strategy, and the 55-to-64 employer population is the use case where DPC integration, telehealth, and chronic disease management programs deliver the most concentrated return relative to their cost.
The 55-to-64 cohort this article examines represents the pre-Medicare version of the coverage and product design problem LFP-16.01 addresses post-65; both articles examine the entrepreneurial older worker whose health complexity and purchasing power exceed what the small group market is designed to serve, and LFP-16.01 continues the analysis from the moment Medicare eligibility transforms the coverage structure.

Sources cited in this article.

  1. AARP. "The Value of Experience: AARP Multicultural Work and Jobs Study." AARP Research, July 2022, www.aarp.org/research/topics/economics/info-2022/multicultural-work-jobs-study.html.
  2. Board of Governors of the Federal Reserve System. "Survey of Consumer Finances, 2022." Federal Reserve, Oct. 2023, www.federalreserve.gov/releases/z1/dataviz/dfa/distribute/chart/.
  3. Bureau of Labor Statistics. "Current Population Survey: Self-Employment by Age, 2023." U.S. Department of Labor, 2024.
  4. Centers for Disease Control and Prevention. "National Health Interview Survey: Selected Measures of Chronic Conditions among Adults Aged 18 and Over." National Center for Health Statistics, 2023.
  5. Ewing Marion Kauffman Foundation. "Who Is the Entrepreneur? Race and Ethnicity, Age, and Immigration Trends among New Entrepreneurs in the United States, 1996–2019." Trends in Entrepreneurship, no. 9, Kauffman Foundation, 2020, www.kauffman.org.
  6. HRA Council. "ICHRA Annual Report 2024: The State of Individual Coverage HRAs." HRA Council, 2024.
  7. Kaiser Family Foundation. "2024 Employer Health Benefits Survey." KFF, Oct. 2024, www.kff.org/health-costs/2024-employer-health-benefits-survey/.
  8. Milliman. *Milliman Health Cost Guidelines*. Milliman, 2024.
  9. Peterson-KFF Health System Tracker. "How Do Health Expenditures Vary Across the Population?" Peterson Center on Healthcare and KFF, 2024, www.healthsystemtracker.org/chart-collection/health-expenditures-vary-across-population/.